The cost of over-the-counter (OTC) equivalent drugs for patients in Japan is set to climb by 25% in the near future. The measure comes as part of new healthcare policies aiming to ease the financial burden on the national healthcare system. However, critics argue the move will put patients, particularly those on fixed incomes or with chronic conditions, under significant financial stress.

The policy is part of Japan's broader strategy to control healthcare expenditure amidst an aging population and an increase in chronic diseases. OTC drugs, which are cheaper alternatives to prescription medications, were previously absorbed by the healthcare system. This has stark implications for Japanese society where respect for elder citizens and their well-being is a deeply rooted cultural value.

In comparison to the US, where patients often bear a significant portion of prescription costs, Japan has maintained relatively low patient contributions for medication. Although a 25% increase is a significant jump in Japan, it remains lower than the cost burden experienced by many Americans. EU countries generally work to keep medication costs lower for patients, with cost-sharing mechanisms varying widely across member states.